---
$id: https://graph.org.ai/products/commodity/51131710
$type: Product
source: UNSPSC
code: "51131710"
title: "Eptifibatide"
class: "51131700"
classTitle: "Thrombolytic drugs and platelet aggregation inhibitors"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Eptifibatide

**UNSPSC Code**: 51131710
**Class**: [Thrombolytic drugs and platelet aggregation inhibitors](Thrombolytic drugs and platelet aggregation inhibitors.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiplatelet agent with the molecular formula C35H49N11O9S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NA8320J834, chemically known as 1,2,3-trihydroxypropanol but generally known as eptifibatide, which bears US NIH Compound Identifier 753. European Medicines Agency schedules Eptifibatide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12498MIG. The term EPTIFIBATIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). World Health Organization schedules eptifibatide in its Anatomical Therapeutic Chemical (ATC) Classification. EPTIFIBATIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule eptifibatide under HS 29349990 and SITC 51579. As of Q4 2014, EPTIFIBATIDE remains the US FDA Preferred Term for this commodity. Eptifibatide bears US NLM identifiers UMLS ID C0253563 and NCI Concept Code C47516. SMILES: OC(CO)CO.

